Heme: A regulator of rat hepatic tryptophan 2,3-dioxygenase?

被引:62
|
作者
Ren, SY
Correia, MA
机构
[1] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA
关键词
tryptophan 2,3-dioxygenase; hepatic heme depletion; heme regulation; 3,5-dicarbethoxy 2,6-dimethyl-4-ethyl-1,4-dihydropyridine; de novo synthesis; dexamethasone induction;
D O I
10.1006/abbi.2000.1755
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The hepatic cytosolic hemoprotein tryptophan 2,3-dioxygenase (TDO) is the rate-limiting enzyme in tryptophan catabolism and thus plays a key role in regulating the physiological flux of tryptophan into relevant metabolic pathways. The TDO protein is induced by corticosteroids such as dexamethasone (DEX) and is stabilized by its prosthetic heme, In rats, acute chemically induced hepatic heme depletion reduces the functional hepatic TDO levels to 25-30% of basal levels within 1 h, and this decrease persists beyond 28 h of heme depletion at which time only 25-30% of the protein is available for heme incorporation. Since this could stem from impaired de novo synthesis and/or instability of the newly synthesized apoTDO protein in the absence of heme, we examined the specific role of heme in these events in a previously validated rat model of acute hepatic heme depletion triggered by the P450 suicide substrate 3,5-dicarbethoxy 2,6-dimethyl-4-ethyl-1,4-dihydropyridine. We now show that exogenous heme can reverse the functional impairment of the enzyme observed during hepatic heme depletion and fully restore the impaired DEX-mediated induction of the enzyme to normal. Furthermore, through Northern/slot blot analyses coupled with nuclear run-on studies, we now document that this heme regulation of TDO is exerted primarily at the transcriptional level. Immunoblotting analyses also reveal corresponding changes in the TDO protein, thereby establishing that heme is necessary for DEX-inducible TDO mRNA transcription and subsequent translation. Thus, the TDO gene may contain heme-regulatory elements in addition to the reported glucocorticoid-responsive elements. Together, these findings suggest that clinically, hepatic heme deficiency may enhance the tryptophan flux into synthetic (serotonergic) pathways, not only by depriving prosthetic heme for a functionally competent TDO hemoprotein, its primary catabolic enzyme, but also by impairing the de novo synthesis of this enzyme. (C) 2000 Academic Press.
引用
收藏
页码:195 / 203
页数:9
相关论文
共 50 条
  • [31] Identification and Characterization of a Novel Dual Inhibitor of Indoleamine 2,3-dioxygenase 1 and Tryptophan 2,3-dioxygenase
    Yoshioka, Saeko
    Ikeda, Tomonori
    Fukuchi, Sogo
    Kawai, Yurika
    Ohta, Katsumi
    Murakami, Hisashi
    Ogo, Naohisa
    Muraoka, Daisuke
    Takikawa, Osamu
    Asai, Akira
    INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH, 2022, 15
  • [32] Indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase expression in HPV infection, SILs, and cervical cancer
    Venancio, Paloma Almeida
    Lopes Consolaro, Marcia Edilaine
    Derchain, Sophie Francoise
    Boccardo, Enrique
    Villa, Luisa Lina
    Maria-Engler, Silvya Stuchi
    Campa, Ana
    Discacciati, Michelle Garcia
    CANCER CYTOPATHOLOGY, 2019, 127 (09) : 586 - 597
  • [33] THE EFFECTS OF A NOVEL AND SELECTIVE INHIBITOR OF TRYPTOPHAN 2,3-DIOXYGENASE ON TRYPTOPHAN AND SEROTONIN METABOLISM IN THE RAT
    SALTER, M
    HAZELWOOD, R
    POGSON, CI
    IYER, R
    MADGE, DJ
    BIOCHEMICAL PHARMACOLOGY, 1995, 49 (10) : 1435 - 1442
  • [34] A narrative review of the roles of indoleamine 2,3-dioxygenase and tryptophan-2,3-dioxygenase in liver diseases
    Zhou, Qihui
    Shi, Yu
    Chen, Chao
    Wu, Fengtian
    Chen, Zhi
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (02)
  • [35] MODE OF INHIBITION OF RAT-LIVER TRYPTOPHAN 2,3-DIOXYGENASE BY MELATONIN
    WALSH, HA
    DAYA, S
    WHITELEY, CG
    JOURNAL OF PINEAL RESEARCH, 1994, 16 (04) : 188 - 192
  • [36] Modeling Tryptophan/Indoleamine 2,3-Dioxygenase with Heme Superoxide Mimics: Is Ferryl the Key Intermediate?
    Monday, Pritam
    Wijeratne, Gayan B.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2020, 142 (04) : 1846 - 1856
  • [37] A NEW METHOD FOR THE ASSAY OF TRYPTOPHAN 2,3-DIOXYGENASE
    MUNOZCLARES, RA
    COOK, JS
    SMITH, SA
    POGSON, CI
    FEBS LETTERS, 1980, 117 (01): : 265 - 268
  • [38] Comparative Studies of Human Indoleamine 2,3-dioxygenase and Tryptophan Dioxygenase
    Yeh, Syun-Ru
    Lewis-Ballester, Ariel
    Batabyal, Dipanwita
    Egawa, Tsuyoshi
    Lu, Changyuan
    Lin, Yu
    Marti, Marcelo A.
    Capece, Luciana
    Estrin, Dario A.
    XXII INTERNATIONAL CONFERENCE ON RAMAN SPECTROSCOPY, 2010, 1267 : 283 - 283
  • [39] Tryptophan 2,3-dioxygenase; structural and mechanistic studies
    Thackray, Sarah J.
    Anderson, Ross J. L.
    Mowat, Chris
    Bruckmann, Chiara
    Chapman, Stephen K.
    JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY, 2007, 12 (SUPPL 1): : S92 - S93
  • [40] MECHANISM OF INHIBITION OF TRYPTOPHAN 2,3-DIOXYGENASE BY AQUAYAMYCIN
    NOZAKI, M
    OKUNO, S
    FUJISAWA, H
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1971, 44 (05) : 1109 - +